Hair Loss Was Just the Start. Ozempic Users Are Also Reporting Nail Trouble

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: Gizmodo
Hair Loss Was Just the Start. Ozempic Users Are Also Reporting Nail TroubleWorldPing
Image via Gizmodo.

What happened

A pair of studies have found evidence that GLP-1 users are more likely to lose their hair and nails.

Key facts

  • A pair of studies have found evidence that GLP-1 users are more likely to lose their hair and nails.
  • Reported by Gizmodo and published Fri, 02 Oct 2026 19:25:43 UTC.

Why it matters

Platform, chip and AI decisions set the terms other companies have to build on, so a single announcement here tends to ripple through products, supply chains and regulation.

What to watch next

  • Availability, pricing and rollout regions
  • Independent testing or verification of the claims made
  • Responses from regulators and competing platforms

Coverage timeline

When each newsroom published on this story, oldest first — all times UTC.

  1. Tesla sustains its EV sales momentum despite US troubles

  2. Rivian’s sales pop as the company’s big R2 bet starts to pay off

  3. Big Oil Perfected Sideways Drilling. A Startup Wants to Do the Same With Nuclear Waste

  4. Hair Loss Was Just the Start. Ozempic Users Are Also Reporting Nail Trouble

Sources

The original report was published by Gizmodo. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at Gizmodo

Related WorldPing coverage

The Verge
WorldPing
The Verge

Rivian’s sales pop as the company’s big R2 bet starts to pay off

Rivian had high hopes for its more affordable R2 vehicle - and so far, those hopes appear to be paying off. The company released its third-quarter production and delivery numbers today, reporting 19,751 vehicles produced and 19,248 delivered.

Brief by WorldPing · Original reporting by The Verge